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Background
Since 2003 seven laboratories of the International Net-
work of Pasteur Institutes have implemented HIV-1 geno-
typic drug resistance tools. These tools were then applied
to study primary antiretroviral (ARV) resistance in drug-
naïve HIV positive pregnant women living in central
Africa (Cameroon, Central African Republic or CAR) and
South-East Asia (Cambodia, Vietnam).
Methods
HIV-1 positive ARV naïve pregnant women who gave their
written informed consent participated to the study. In
addition to clinical examination, EDTA blood samples
were collected for T-CD4 count, plasma HIV-RNA viral
load determination and ARV genotypic resistance testing
following the French ANRS AC11 guidelines for both
reverse transcriptase and protease genes. HIV genetic
sequences were analysed with the latest version of the
ANRS, Stanford HIVdb and IAS algorithms. HIV-1 sub-
types were determined by phylogenetic analysis and
BLAST search. Statistical comparisons of the results were
performed through the Fisher's exact test or Kruskall-wal-
lis test, whenever appropriated.
Results
Overall, 362 women participated: 95 in Cameroon, 93 in
CAR, 122 in Cambodia, and 52 in Vietnam. At inclusion,
the median age was 26 years (IQR:22-30). For most of the
women (94%), HIV status was known for less than a year
and 31% were in their first pregnancy. The median CD4
counts was 358 cells/mm3 (IQR: 220-551). The median
HIV-RNA viral load was 4.6 Log RNA copies/ml (IQR: 4-
5) in Cameroon and CAR.
Phylogenetic analysis revealed that 96% and 98% of viral
sequences from Cambodia and Vietnam, respectively,
belonged to the CRF01_AE subtype. In Cameroon, 60% of
the samples clustered with CRF02_AG subtype, but 10
other subtypes were encountered. In CAR, 40% and 22%
of samples belonged to CRF11 and A1 subtypes respec-
tively. Seven strains of 362, 1.9%, (4 from Cambodia, 2
from Vietnam and 1 from Cameroon) harboured muta-
tions associated to major ARV resistance in RT gene: 4
with V75M (resistance to D4T), 1 with the K101E (resist-
ant to NVP and EFV) and the last one with the mutation
L210W/T215S (weak resistance to AZT/D4T). In the pro-
tease gene, 3 strains (1 from Cameroon and 2 from Cam-
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bodia) bore N88 alone or associated to M46I, conferring
resistance to IDV and NFV.
Conclusion
This four-sites study confirmed the high genetic diversity
of HIV-1 circulating in Central Africa compared to the
hegemony of CRF01_AE in South-East Asia. Drug resist-
ance mutation survey revealed prevalence below 5% in
this sentinel population, consistent with the recent intro-
duction of ARV in these countries.
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